Nandini Sharrel Menon

32PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 09, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

|Apr 23, 2026
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial.

|Mar 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial.

Vikas Ostwal, Manali Parulekar, Deepali Naughane

|Feb 05, 2026
Presentation and Outcomes of CNS Tumors Associated With Phakomatoses Syndromes From a Specialized Neuro-Oncology Practice in India.

Anuradha Krishnan, Yamini Baviskar, Abhishek Chatterjee

|Jan 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).

Vanita Noronha, Vijay Patil, Nandini Menon

|Dec 31, 2025
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India.

Ajaykumar Singh, Vanita Noronha, Vijay Patil

Pageof 6

Frequent Collaborators

23 joint publications

Vanita Noronha

16 joint publications

Kumar Prabhash

8 joint publications

Akhil Kapoor

7 joint publications

Vijay Patil